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The rise of antimicrobial resistance in many pathogens presents a major challenge to the
treatment and control of infectious diseases. Furthermore, the observation that drug-resistant
strains have risen to substantial prevalence but have not replaced drug-susceptible strains
despite continuing (and even growing) selective pressure by antimicrobial use presents an
important problem for those who study the dynamics of infectious diseases. While simple
competition models predict the exclusion of one strain in favour of whichever is ‘ﬁtter’, or
has a higher reproduction number, we argue that in the case of Streptococcus pneumoniae
there has been persistent coexistence of drug-sensitive and drug-resistant strains, with neither
approaching 100 per cent prevalence. We have previously proposed that models seeking to
understand the origins of coexistence should not incorporate implicit mechanisms that
build in stable coexistence ‘for free’. Here, we construct a series of such ‘structurally neutral’
models that incorporate various features of bacterial spread and host heterogeneity that have
beenproposedasmechanismsthatmaypromotecoexistence.Weasktowhatextentcoexistence
is atypical outcome in each. We ﬁnd that while coexistence is possible in each of the models we
consider, it is relatively rare, with two exceptions: (i) allowing simultaneous dual transmission
of sensitive and resistant strains lets coexistence become a typical outcome, as does (ii) model-
ling each strain as competing more strongly with itself than with the other strain, i.e.
self-immunity greater than cross-immunity. We conclude that while treatment and contact
heterogeneitycanpromotecoexistencetosomeextent,thein-hostinteractionsbetweenstrains,
particularly the interplay between coinfection, multiple infection and immunity, play a crucial
role in the long-term population dynamics of pathogens with drug resistance.
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1. INTRODUCTION
The use of antimicrobial drugs has led to the emergence
and spread of resistant strains of nearly every bacterial
pathogen. For some antimicrobial agents and bacterial
species, resistant strains now comprise nearly 100 per
cent of the bacterial population. A notorious example
is Staphylococcus aureus, which became almost univer-
sally resistant to penicillin within a few years of the
introduction of this drug. Development of extended
spectrum drugs such as oxacillin and methicillin
addressed the emergence of these penicillin-resistant
strains of S. aureus, but resistance to these antibiotics
is now common, and their effectiveness is declining
(McDonald 2006). For other bacterial species,
resistant strains have become clinically important,
but seem to remain at intermediate frequencies,
neither dwindling to zero nor reaching 100 per cent.
Examples include vancomycin resistance inEnterococcus
(McDonald 2006), sulphonamide resistance in
Escherichia coli (Enne et al. 2001) and, seemingly,
penicillin (and other drug) resistance in Streptococcus
pneumoniae. *Author for correspondence (ccolijn@gmail.com).
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why a gene would have a frequency near zero—if it is on
average deleterious; or near 100 per cent—if it is
on average beneﬁcial. In the simplest models of compe-
tition between drug-susceptible and drug-resistant
strains, competitive exclusion is predicted, with the
‘ﬁtter’ strain—that with the higher basic reproductive
number R0 at a given level of antimicrobial use—
winning (Lipsitch 2001). A prevalence near 0 or
100 per cent may be attributable to mutation–selection
balance. This would occur if (for example) the resistant
strain has lower ﬁtness in the population as a whole, but
reappears at some frequency owing to mutation or
resistance gene acquisition (Cohen & Murray 2004).
Alternatively, the resistant strain may be selectively
favoured but occasionally lose its resistance determi-
nant (Vilhelmsson et al. 2000), producing a frequency
near 100 per cent. For hospital-acquired pathogens, a
migration–selection balance could maintain poly-
morphism, if a resistant strain is selectively favoured
in the hospital where antibiotic usage is high but con-
stantly ‘diluted’ by the inﬂux of sensitive strains, that
are favoured in the community, as new patients are
admitted (Lipsitch et al.2 0 0 0 ). For commensal organ-
isms like E. coli that form a permanent part of the
normal ﬂora, it is possible that selection by antimicrobial
use within hosts may be countered by novel introduction
of (mainly drug-sensitive) strains from food or other
sources—a within-host form of migration–selection
balance (Levin et al. 1997; Stewart et al. 1998).
For S. pneumoniae, a common but not universal
inhabitant of the nasopharyngeal ﬂora, none of these
explanations seems to ﬁt in a simple way. In §2, we
make the case that S. pneumoniae is showing long-
term (in this case over many years, up to a decade)
persistence of both drug-sensitive and drug-resistant
strains. The explanation of mutation–selection balance
(or recombination–selection balance, since pneumo-
cocci undergo very high rates of recombination; Feil
et al. 2001) is implausible because typical frequencies
of resistance in populations are not near zero or one,
but rather in the tens of per cent, and because these
frequencies can vary so rapidly (Dagan et al. 2008).
The explanations relevant to hospital-acquired patho-
gens or to permanent commensals are not applicable
because the duration of pneumococcal colonization is
of the order of weeks to a few months (Bogaert et al.
2004; Hogberg et al. 2007); the prevalence is well
below 100 per cent in developed countries (Bogaert
et al. 2004); and there is no known source of ‘inﬂux’
of drug-sensitive strains, since it is an obligate human
colonizer (Bogaert et al. 2004). Nonetheless, as will
become clear below, we consider variations on these
themes as possible explanations of the coexistence of
resistant and susceptible pneumococci.
In a recent paper (Lipsitch et al. 2009), we proposed
that when using mathematical models to understand
the mechanisms of coexistence of pathogen strains in a
host population, the underlying model should not
create ‘coexistence for free’. More technically, when
applied to two biologically indistinguishable strains,
the model’s ecological dynamics should be independent
of the strain composition of the population, and the
model should not predict a stable equilibrium frequency
of the two strains, but rather permit any long-run fre-
quency given some possible initial conditions. In that
paper, we deﬁne sufﬁcient conditions under which a
model meets these criteria when applied to indistin-
guishable strains; we call such models ‘structurally
neutral models’. Here, our goal is to start from simple
structurally neutral models, and ask whether they con-
sistently predict stable coexistence when applied to
resistant and sensitive strains, which are of course not
indistinguishable. We initially consider ﬁve models
(A–E), each of them structurally neutral. Apart from
the ﬁrst, each one incorporates some mechanism that
may potentially promote coexistence of competing
strains, and we explore the ability of each model to do
so. Finally, we consider the possibility that the two
strains experience some degree of strain-speciﬁc immu-
nity, a feature that breaks the structural neutrality of
the model, but which may possibly reﬂect biological
reality. Under these circumstances, we repeat analyses
of models A–E and ﬁnd that the conditions for coexis-
tence are considerably expanded. A number of factors,
such as trade-offs in transmissibility and virulence,
spatial heterogeneity or different selective pressures
in weakly interconnected subpopulations, contact struc-
ture, heterogeneous host susceptibility and mechanisms
for sustained non-equilibrium coexistence are all likely
to play a role in maintaining strain diversity. We
developed models A–E in light of several of these.
Before describing the models, we review the evidence
supporting long-term, apparently stable coexistence of
drug-sensitiveanddrug-resistantstrainsofS.pneumoniae.
2. EVIDENCE FOR STABLE COEXISTENCE
OF DRUG-RESISTANT AND
DRUG-SENSITIVE STREPTOCOCCUS
PNEUMONIAE
Resistant strains of S. pneumoniae have been reported
to date for every important drug class used to treat it,
with the notable exception of vancomycin. In some set-
tings, there is evidence that the prevalence of resistance
has been increasing in recent years. Among invasive iso-
lates in the USA prior to the introduction of the
pneumococcal conjugate vaccine (which reduced resist-
ance by targeting mainly those serotypes most
associated with resistance; Kyaw et al. 2006), there
was a trend of increasing prevalence of resistance or
non-susceptibility to penicillin, cephalosporins, macro-
lides and trimethoprim sulfamethoxazole (Whitney
et al. 2000; McCormick et al. 2003). In Canada, similar
trends were observed for penicillin non-susceptibility
and macrolide resistance, though not for trimethoprim
sulfamethoxazole (Powis et al. 2004). The absolute
increase in the prevalence of resistance was of the
order of 1–4% per year for each of these populations.
In The Netherlands between 1994 and 1999, most pneu-
mococci remained susceptible to both penicillin and
macrolides, but there was a modest upward trend of
less than 1 per cent per year in absolute prevalence
(de Neeling et al. 2001).
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lence of resistance has been at a plateau for a number of
years. The European Antimicrobial Resistance Surveil-
lance System (EARSS) has reported antimicrobial
susceptibilities for pneumococci since 2001. In the
EARSS report up to 2006, there were 21 countries that
submitted an average of 100 or more isolates per year
for susceptibility testing, for some period starting as
early as 2001 and ending in 2006 (Anonymous 2007).
Among these 21 countries, there were only six showing
evidence of a trend in the prevalence of penicillin non-
susceptibility (decreasing in four, increasing in two),
four with a signiﬁcant trend in the prevalence of penicil-
lin resistance (increasing in two and decreasing in two)
and eight with a trend in macrolide resistance (increasing
in six and decreasing in two). Perhaps the longest time
series on resistance we have found in the literature is a
large but non-systematic sample of clinical pneumococci
from Spain, whose susceptibility patterns have been
traced since as early as 1979. Non-susceptibility to peni-
cillin remained roughly ﬁxed between the late 1980s and
1996, ﬂuctuating around 60 per cent in non-invasive iso-
lates and around 40 per cent in invasive ones (Fenoll
et al. 1998); a subsequent report showed this trend con-
tinued (with perhaps a decline of less than 5%)
through 2001 (Fenoll et al. 2002). The prevalence of cefo-
taxime resistance remained around 20 per cent from the
late 1980s through 2001 (Fenoll et al. 1998, 2002),
though erythromycin resistance was increasing during
the ﬁrst reporting period, up through 1996 (Fenoll
et al. 1998); a 2004 sample from the same group (Cala-
tayud et al. 2007), combined with EARSS data from
Spain (Anonymous 2007), suggests that erythromycin
resistance plateaued by the early part of this decade
and may be starting to decline modestly.
Collectively, these studies show that for the most
commonly used antimicrobial classes—penicillins,
cephalosporins and macrolides—resistance is changing
little, if at all, over the decadal scale in many popu-
lations, though in the USA, Canada and Spain in the
1990s, there was a distinctive upward trend in macrolide
resistance. One caveat in interpreting these studies is
that essentially all of them use isolates from invasive dis-
ease, rather than nasopharyngeal carriage, which is the
‘reservoir’ for infection and the site of most selection by
antimicrobials (Bogaert et al. 2004; Dagan & Lipsitch
2004). However, invasive isolates are a subset of carriage
strains, hence coexistence of resistant and sensitive
strains among invasive isolates suggests the same
among carriage isolates, and broad patterns of resistance
appear similar among carriage and invasive isolates
(Huang et al. 2005; Kyaw et al. 2006).
Howcanwereconcilethiscommonobservationwiththe
model-basedpredictionthat,underaconstantlevelofanti-
microbial use, the rate of change in the prevalence of
resistance should be either constantly positive (leading
eventually to 100% prevalence) or constantly negative
(leading eventually to 0% prevalence)? There are several
possibilities. One is that as resistance has grown, there
has been a corresponding decline in antimicrobial use, so
that what we see is essentially the peak of resistance,
which will soon decline as antimicrobial use reaches sus-
tained lower levels. This interpretation is hard to
reconcile with several facts. First, within Europe, there is
enormous (approximately threefold) variation between
countries in the intensityof antimicrobial use, which corre-
lates closely with the prevalence of penicillin resistance in
pneumococci (Goossens et al.2 0 0 5 ); second, the apparent
plateaus in resistance appear to be scattered throughout
the low-, middle- and high-use countries, while the
countries in which resistance is increasing tend often to
be those with low levels of antimicrobial use and low
levels of resistance (Anonymous 2007). Thus it is difﬁcult
to believe that the plateaus mainly correspond to those
areas that are changing their level of use from a high level
that promotes resistance to a low level that opposes its rise.
A second possible reconciliation is that the natural
time scale for trends in resistance is very long, and
that apparent plateaus are concealing very slow
increases. This seems unlikely for two reasons. First,
one can make a crude calculation that with approxi-
mately 0.5–1.5% of the population of a European
country taking penicillins each day (Goossens et al.
2005), the incidence of new prescriptions might be of
the order of 3–6% per month, and probably higher in
the age groups that carry pneumococci. Since the dur-
ation of pneumococcal carriage is of the order of 1–2
months (Hogberg et al. 2007), use of penicillins argu-
ably reduces the expected duration of pneumococcal
carriage for sensitive strains by roughly 3–12%. A
resistant strain, which avoided that clearance, might
therefore have a roughly 3–12% advantage in trans-
mission, excluding any ﬁtness cost associated with
penicillin resistance (Trzcinski et al. 2006). Given that
the ‘generation time’ of pneumococcal carriage is
about a month or two, a ﬁtness advantage of even
1 per cent for resistant strains should result in an
about 1 per cent per month exponential increase in the
prevalence odds of resistant strains (Lipsitch 2001).
Here (unlike the ﬁgures above) we are describing
proportional increases, not absolute increases, so a
1 per cent per month exponential increase corresponds
to a doubling in about 5–6 years. Thus, under fairly
conservative assumptions, the time scale of change
should be faster than what we currently observe. More-
over, recently published data from Israel indicate that
the prevalence of resistance can change even more
rapidly, with resistance ﬂuctuating roughly two- to
threefold in a seasonal cycle, increasing to a winter
peak (as antibiotic use increases) and declining to a
summer trough (Dagan et al. 2008). Thus, it is difﬁcult
to believe that the slow changes observed over years to
decades reﬂect an inability of pneumococcal
populationstorespondrapidlytoselectionforresistance.
If plateaus in the prevalence of resistance are real for
S. pneumoniae, and they cannot be explained either by
declines in antimicrobial use or by a naturally slow time
scale for changes in the prevalence of resistance, we
believe that existing models are missing something criti-
cal in the transmission dynamics of resistant organisms.
Under this hypothesis, a model is needed in which
approximately constant levels of antimicrobial use
lead to stable equilibria with a prevalence of resistance
that is neither almost zero nor almost 100 per cent, i.e.
in which competitive exclusion is not the expected out-
come of competition between resistant and sensitive
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possibility in greater detail and explore several models
for their ability to replicate the apparently stable, but
intermediate, prevalence of resistance observed in
many pneumococcal populations.
3. METHODS
3.1. Five model structures
We develop ﬁve models of S. pneumoniae colonization.
Becausecolonizationismuchmorecommonthaninvasive
disease, and colonized persons are thought to be the main
source ofpneumococcal transmission,we ignore diseasein
these models and consider colonization only; we thus use
the term ‘infection’ interchangeably with colonization.
In each model there are two strains, one that is sen-
sitive to a particular antibiotic and one that is resistant.
In reality, a resistant strain may retain some suscepti-
bility to that drug. In our models, each strain has a
clearance rate independent of treatment, so that if we
were to model treatment effective against both strains,
this could be modelled as an increase in the overall
clearance rate. We therefore model the differential
effect of therapy on the two strains as treatment that
has no effect on the strain designated as ‘resistant’.
In each of our models, infection by both strains is poss-
ible. The extent to which dual infection occurs in the
models depends on whether the presence of a resident
strain inhibits acquisition of a second strain upon sub-
sequent exposure, and (in one case) on the relative
ﬁtness of the strains. We do not explicitly model the
dynamics of host immunity (which may in principle take
the form of reduced acquisition rates and/or reduced dur-
ation of carriage); rather, the assumed values of
transmission and clearance rates are meant to average
over more and less immune members of the population.
The ﬁrst model considered is a simple model in which
individuals may be susceptible, infected (and infec-
tious) with either strain or dually infectious with both
strains. The second is an extension of this simple
model, with explicit accounting for those individuals
currently on antibiotic treatment. Similar ‘habitat
heterogeneity’ has been shown in ecological models to
promote coexistence of competing populations
(Tilman & Pacala 1993). The third model is also an
extension of the ﬁrst, and includes a ‘day-care’ environ-
ment that is attended by a portion of the population
and that is characterized by both high transmission
and high rates of treatment. The day care thus provides
a different form of habitat heterogeneity, and can also
be thought of as a school or workplace or any environ-
ment in which there is more contact and a greater rate
of treatment than in the general population. The fourth
model allows the possibility that if there is competition
between low ﬁtness strains and a higher ﬁtness strain,
the higher ﬁtness strain may superinfect hosts colonized
with the low ﬁtness strain and may subsequently out-
compete the low ﬁtness strain within these dually
infected hosts. The ﬁfth model borrows some inspiration
from prior models of long-term commensals like E. coli
(Levin et al. 1997; Stewart et al. 1998), and permits the
persistence of subpopulations of drug-sensitive strains
within individuals carrying mainly the resistant strain,
and vice versa. Unlike those prior models, it is a pure
transmission model that does not assume entry of novel
strains from outside the model, and it allows clearance
of S. pneumoniae from a host. In each model, as in the
framework given in Lipsitch et al. (2009),i ti sp o s s i b l e
to be colonized with either the drug-sensitive or the
drug-resistant strain alone, with both or with neither.
Model A is a simple model with single and dual colo-
nization, illustrated in ﬁgure 1a. This basic model serves
as a basis for constructing the more complex models
B–E described below. Model A contains four classes
of individuals as described above: X (susceptible), IS
(infected with the sensitive strain), IR (infected with
the resistant strain) and ISR (infected with both
strains). Infection occurs at a rate proportional to a
transmission rate constant bs or br for the sensitive
and resistant strains, respectively, and to the prevalence
of singly or dually infected hosts. Dually infected
individuals may transmit either the susceptible or
resistant strain upon contact, with equal probability,
so that the forces of infection are bs(IS þ qISR) for the
sensitive strain and br(IR þ qISR) for the resistant
strain; throughout this paper, we ﬁx q ¼ 1/2 to indicate
that dually infected hosts are equally infectious as the
average infectiousness of singly infected hosts with the
sensitive or resistant strain alone. An individual in
class IS can move to class ISR upon reinfection with
the resistant strain, but reinfection is somewhat less efﬁ-
cient than primary infection, occurring at a per capita
rate 1/2   k   1 times as great. We chose to have 1/2
as the lower bound for k to model the assumption
that infection only confers partial immunity and to
allow reinfection and coinfection to play a role in the
model dynamics. Likewise, individuals in class IR are
partially protected against reinfection with the sensitive
strain. In these models, reinfection results in partial
strain replacement within the host; singly infected indi-
viduals move to the dually infected class while dually
infected individuals may move back to either class IS
or IR upon reinfection, indicating replacement of one
strain by a ‘new copy’ of the other strain. With prob-
ability c ¼ 1/2, a reinfection of a dually infected
individual replaces the same strain, resulting in no
change. The choice c ¼ q ¼ 1/2 guarantees the struc-
tural neutrality of the base model. Natural clearance
occurs at rate u from all infected states and results in
the return of individuals to the class of uninfected
individuals. We model treatment at rate t as taking
individuals infected with the sensitive strain back to
the uninfected class, and dually infected individuals
to the resistant class, as treatment cures the sensitive
part of the infection. We do not model acquired resist-
ance (the de novo appearance of a resistant variant
upon treatment of a sensitive strain) because we are pri-
marily concerned with resistance to penicillins and
macrolides, each of which requires the import of a
novel gene or allele from an already-resistant strain by
transformation (or transconjugation). This event occurs
very rarely, since it requires co-colonization with a sensi-
tive recipient and a resistant donor, combined with
selection for resistance that preferentially selects a trans-
formantoratransconjugant (rather than just the donor).
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Figure 1. Schematic of the models. X indicates susceptible, IS infectious with the sensitive strain and IR with the resistant strain,
while ISR indicates dually infected individuals. (a) In model A, dotted arrows indicate reinfection, dot-dashed arrows indicate
natural clearance of infection and dashed arrows indicate treatment (and its waning, in model B). (b) In model B, the subscript
T indicates the treated class. (c) In model C, the subscript 1 indicates the general population while 2 indicates the day-care/
school subpopulation. (d) In model D, ISR speciﬁes dually infected individuals who have predominant sensitive infections and
IRS speciﬁes dually infected individuals who have predominantly resistant infections. (e) In model E, in addition to the singly
infected classes, there are three dually infected classes ISS, ISR and IRR.
Origins of persistent coexistence C. Colijn et al. 909
J. R. Soc. Interface (2010)The model is given by equation (3.1). The fact that
the model is neutral for identical strains means that
we are not introducing coexistence ‘for free’ by building
it into the model structure in a fundamental way.
dIS
dt
¼ bsStotX   kbrRtotIS  ð u þ t1ÞIS
þ kcbsStotISR;
dIR
dt
¼ brRtotX   kbsStotIR   uIR
þ kcbrRtotISR þ t1ISR;
dISR
dt
¼ kbrRtotIS þ kbsStotIR  ð u þ t1ÞISR
  kcbsStotISR   kcbrRtotISR
and X ¼ 1   IS   IR   ISR;
9
> > > > > > > > > > > > > > > > > > > =
> > > > > > > > > > > > > > > > > > > ;
ð3:1Þ
where Stot ¼ IS þ qISR and Rtot ¼ IR þ qISR.
Model B (ﬁgure 1b) expands upon model A by includ-
ing an explicit class of treated persons, whereastreatment
in model A was an instantaneous event. Treatment may
begiventosusceptibles,whereupontheyenterthetreated
susceptible class (XT) and cannot be successfully infected
by the drug-sensitive strain. Individuals infected with the
sensitive strainand given treatment move to the XT class.
Individualswiththeresistantstrainwhoarebeingtreated
(classRT)cannotbeproductivelyinfectedbythesensitive
strain. Dually infected individuals given treatment move
totheRTclass.Individualsendtreatmentandexitclasses
XTand RTat ratew, whereupon individuals move back to
XandIR,respectively.Thedynamicsofreinfectionarethe
same as in model A. Model B is given by equation (3.2)
and reduces to model A in the limit where the two strains
are biologically identical, because it does not make sense
to treat only one of the two identical strains, so either
the treatment rate must be 0 (reducing the model
to model A) or treatment must apply equally well to
both strains, so that the model would need a treated
compartment for both.
dXT
dt
¼ t1X þ t1IS   wXT   brRtotXT þ uIRT;
dIS
dt
¼ bsStotX   kbrRtotIS  ð u þ t1ÞIS
þ kcbsStotISR;
dIRT
dt
¼ brRtotXT þ t1ISR þ t1IR   wIRT   uIRT;
dIR
dt
¼ brRtotX   kbsStotIR   uIR
þ kcbrRtotISR   t1IR þ wIRT;
dISR
dt
¼ kbsStotIR þ kbrRtotIS  ð t1 þ uÞISR
  kcðbsStot þ brRtotÞISR
and X ¼ 1   XT   IS   IRT   IR   ISR;
9
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > =
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > ;
ð3:2Þ
where Stot ¼ IS þ qISR and Rtot ¼ IR þ IRT þ qISR.
Model C (ﬁgure 1c) expands on model A in a different
direction, by including two subpopulations with different
transmission dynamics. In model C, the population is het-
erogeneous, with a proportion hexperiencing both a higher
rateoftransmissionandahigherfrequencyofantimicrobial
treatment than the remainder of the population; the two
groups might represent younger versus older children or
day-care attendees versus non-day-care attendees. The
model structure incorporates two copies of model A: one
for the general population (group 1), and one for the day-
care environment (group 2), in which both the contact
rate and the treatment rate are higher. The two groups
arecoupledviatheforceofinfection terms,which summar-
izes the extent to which contact between the groups is
assortative or random, the portions of the population in
each group and the different contact rates in the groups.
AsinmodelA,thelimitingcaseofindistinguishablestrains
for this model would mean that transmission rates for the
strains are the same and the treatment rate is 0, and this
would result in a structurally neutral model. The model
is given by
dIS1
dt
¼bsðp11S1tot þp12S2totÞX1
 kbrðp11R1tot þp12R2totÞIS1  ðuþt1ÞIS1
þkcbsðp11S1tot þp12S2totÞISR1;
dIR1
dt
¼brðp11R1tot þp12R2totÞX1
 kbsðp11S1tot þp12S2totÞIR1  uIR1
þkcbrðp11R1tot þp12R2totÞISR1 þt1ISR1;
dISR1
dt
¼kbrðp11R1tot þp12R2totÞIS1
þkbsðp11S1tot þp12S2totÞIR1
 ðuþt1ÞISR1  kcbsðp11S1tot þp12S2totÞ
 ISR1  kcbrðp11R1tot þp12R2totÞISR1;
dIS2
dt
¼bsðp21S1tot þp22S2totÞX2
 kbrðp21R1tot þp22R2totÞIS2
 ðuþt2ÞIS2 þkcbsðp21S1tot
þp22S2totÞISR2;
dIR2
dt
¼brðp21R1tot þp22R2totÞX2
 kbsðp21S1tot þp22S2totÞIR2  uIR2
þkcbrðp21R1tot þp22R2totÞISR2 þt2ISR2
and
dISR2
dt
¼kbrðp21R1tot þp22R2totÞIS2
þkbsðp21S1tot þp22S2totÞIR2  ðuþt2Þ
 ISR2  kcbsðp21S1tot þp22S2totÞISR2
 kcbrðp21R1tot þp22R2totÞISR2;
9
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > =
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > ;
ð3:3Þ
where S1tot ¼ IS1 þ qISR1 and R1tot ¼ IR1 þqISR1 and
similarly for S2tot and R2tot.
Here, pij (i, j [ f1,2g) represents the rate at which
individuals of group i receive potentially infectious
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pij ¼ zi½ð1   gÞmj þ dijg ;
where zi represents the per capita rate at which indi-
viduals of group i make infectious contact and dij is 1
if i ¼ j and 0 otherwise. The number g [[0,1]
measures the degree of assortative mixing, with g ¼
0 corresponding to random mixing and g ¼ 1 corre-
sponding to fully assortative mixing. In these
calculations, m1 ¼ (1 2 h)z1/((1 2 h)z1 þ hz2) is the
proportion of all contacts made by members of
group 1 (the low-contact group) and m2 ¼ 1 2 m1 is
the proportion of contacts made by members of
group 2 (the high-contact group).
ModelD(ﬁgure1d,equations(3.4))departsfrommodel
A in two ways. First, the dually infected category is now
split into two, those who carry primarily the sensitive
strain with a small resistant subpopulation (ISR), and
those who carry primarily the resistant strain with a
small sensitive subpopulation (IRS). Each of these types
of hosts transmits only the predominant strain. Second,
this model assumes that reinfection can occur only when
a strain of higher ‘ﬁtness’ within the host encounters a
hostcarryingastrainoflowerﬁtness.Hereﬁtnessisdeﬁned
ascompetitiveabilitywithinthehostintheabsenceofanti-
biotics, and consistent with prior experimental data, we
assume that the resistant strain is of lower ﬁtness than
the sensitive strain (Andersson & Levin 1999; Trzcinski
et al. 2006). Accordingly, there may be reinfection of indi-
viduals carrying the less ﬁt resistant strain, but there is
no reinfection of those carrying the drug-sensitive strain.
Additionally, this model stipulates that within coinfected
individuals, the more transmissible strain can outcompete
the less transmissible strain (at rate j)s ot h a tt h em o r e
transmissible becomes the dominant one. We also assume
that when evaluating strain coexistence at the population
level, a dually colonized individual is measured as having
only the predominant strain. This assumption
is consistent either with what one would expect from
invasive isolates (which are usually clonal, representing
invasion of a particular strain from the nasopharynx)
orfromcarriageisolatesastypicallycharacterizedbygrow-
ing and characterizing a single colony-forming unit. This
model reduces to a structurally neutral model when the
strains are identical because in this case, neither strain
has higher ﬁtness, so there can be no reinfection, and the
model collapses into model A with k ¼ 0.
dX
dt
¼  ð lS þ lRÞX þ t1IS
þ uðIS þ IR þ ISR þ IRSÞ;
dIS
dt
¼ lSX   uIS   t1IS;
dIR
dt
¼ lRX   uIR þ t1ISR þ t1IRS   klSIR;
dISR
dt
¼ jIRS   t1ISR   uISR
and
dIRS
dt
¼ klSIR   t1IRS   jIRS   uIRS:
9
> > > > > > > > > > > > > > > > > > > =
> > > > > > > > > > > > > > > > > > > ;
ð3:4Þ
Theforcesofinfectionarewrittenasl’sandaregivenby
lS ¼ bSðIS þ ISRÞ
and
lR ¼ bRðIR þ IRSÞ:
Finally, model E (ﬁgure 1e, equations (3.5)) expands
model A in two different ways. Here, reinfection may
result in individuals having more than one ‘copy’ of a
single type of infection, in analogy to the state of simul-
taneous infection with S and R.T h i sm o d e lh a ss i x
states in total, and three dually infected states. Further-
more, in this model, simultaneous transmission of a dual
infection may occur when a susceptible individual is in
contact with a dually infected individual; this is a depar-
ture from the assumptions in previous models, where
only one strain could be transmitted at a time. In this
case, a single infection (resulting in the individual
moving from X to IS or IR) occurs with probability rsingle.
When a dually infected ISR individual is in contact with a
susceptible individual and a single infection istobe trans-
mitted, S is transmitted with probability rs and R is
transmitted otherwise. In this model, we do not explicitly
model changes of state within a colonized host, except
through reinfection or clearance; we do not allow for the
possibility that (say) an R host can become an RR host
bygrowthoftheRstrain.Thismodelisalsoastructurally
neutral model for biologically identical strains.
dIS
dt
¼ lX!SX  kðlS þlRÞIS  uIS  t1IS;
dIR
dt
¼ lX!RX  kðlS þlRÞIR
 uIR þt1ISR;
dISS
dt
¼ lX!SSX þklSIS  2cklRISS þcklSISR
 uISS  t1ISS;
dISR
dt
¼ lX!SRX þklRIS þklSIR
 ckðlS þlRÞISR þ2cklSIRR
þ2cklRISS  uISR  t1ISR
and
dIRR
dt
¼ lX!RRX þklRIR  2cklSIRR
þcklRISR  uIRR;
9
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > =
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > ;
ð3:5Þ
where X ¼ 1 2 IS 2 IR 2 ISS 2 ISR 2 IRR, and the forces
of infection are deﬁned as follows:
lS ¼ bsðIS þ2qrSISR þ2qISSÞ;
lR ¼ brðIR þ2qð1 rSÞISR þ2qIRRÞ;
lX!SR ¼ð 1 rsingleÞðbsrS þbrð1 rSÞÞ2qISR;
lX!S ¼ bsðIS þrsingleð2qrSISR þ2qISSÞÞ;
lX!SS ¼ð 1 rsingleÞbs2qISS;
lX!R ¼ brðIR þrsingleð2qð1 rSÞISR þ2qIRRÞÞ
and lX!RR ¼ð 1 rsingleÞbr2qIRR:
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theforcesofinfectionfromsinglyandduallyinfectedindi-
viduals. Those who are dually infected are q times as
infectious with each of their strains as those who are
singly infected; in these simulations, we use q ¼ 1/2
under the assumption of equal infectiousness for dually
and singly infecteds, though this choice is not essential
toretainthe neutralityof themodel (Lipsitch etal. 2009).
3.2. Parameter values
To assess the extent to which coexistence is a ‘generic’
outcome of these models, we deﬁned a set of plausible
ranges for the values of each of their parameters. For
parameters that were common to more than one
model, we set the plausible ranges the same in each
model. Where data were available to constrain the
plausible range of parameters, we used the data to do
so; however, the values of many of these parameters
are difﬁcult or impossible to measure, in which case
we set a broad range of ‘plausible’ values. For each par-
ameter set, we ran the model to near equilibrium (which
was achieved by the end of 1000 simulated months) and
asked whether the model exhibited elimination of one or
the other strain or whether there was stable coexistence
of strains. Stable coexistence was deﬁned as the ﬁnal fre-
quency of the sensitive strain (among all colonized
hosts) between 1 and 99 per cent; frequencies outside
this range were deﬁned as showing competitive exclu-
sion. To assess the frequency of stable coexistence in
parameter space, we created 10 000 parameter sets,
each by an independent uniform draw of all parameters
from their plausible ranges given in table 1; this choice
was made for simplicity and because in general we
do not have data to inform a different distributional
estimate. The ranges for our parameters affect the
portion of simulations with coexistence; as a simple
example, the ranges are chosen so that R0 is greater
than one for both strains; if we had allowed parameter
ranges such that the reproductive number was less
than one, we would have seen some portion of simu-
lations with no infection at all. Since the parameter
ranges are ﬁxed across the model structures, while the
frequency of coexistence in the simulations may not
reﬂect that which would be statistically observed
owing to the real parameters being distributed in a
non-uniform fashion or over ranges other than those
chosen here, it is the qualitative level of coexistence
and particularly the comparison between model
structures that is our focus.
4. RESULTS
4.1. Findings from models A–E
Stable coexistence is possible in each model, but is not
typical in the baseline case of model A; in appendix A,
we show a bifurcation diagram for this model, indicating
that there is a thin band in parameter space in which
stable coexistence is possible (ﬁgure 4).
Figure 2a–d shows the simulations in models A–D
according to their eventual outcome: coexistence
(green), elimination of the drug-sensitive strain (red)
or elimination of the drug-resistant strain (blue). The
three parameters on the axes are bs (the transmission
parameter of the sensitive strain), the ratio of trans-
mission parameters of the resistant to sensitive strain
br/bs and the rate of treatment (or, in the case of
model C, a weighted treatment term [(1 2 h)t1 þ ht2]
and in the case of model D, a modiﬁed treatment
term that also reﬂects the importance of the rate of
within-host takeover and partial immunity to reinfec-
tion: t1/u 2 log(j/u) 2 k). Though there are more
parameters that vary between simulations, these vari-
ables effectively separate the simulations by their
qualitative outcomes in each of these models. We
observe that when the relative transmissibility of the
resistant strain is higher, the sensitive strain is elimi-
nated. When the level of treatment is higher, the
resistant strain takes over at lower levels of relative
transmissibility because increased treatment provides
a greater competitive advantage for resistance. When
the reproductive numbers of the two strains
(R01 ¼ bs=ðu þ t1Þ and R02 ¼ br=u in the simple and
treated class models) are approximately equal, coexis-
tence occurs. This accounts for the placement of the
green near-planar areas in the ﬁgure; see also ﬁgure 4
in appendix A.
Over the sampled parameter ranges, approximately
16 per cent of the simulations exhibit coexistence in
the simplest model, model A, with slightly higher frac-
tions of simulations exhibiting coexistence in model B
(19%; the treated class model) and model C (20%; the
day-care model). Figure 2e–h shows a histogram for
each model depicting the fraction of carried strains
that were resistant at equilibrium over 10 000
simulations.
Model D, in which the sensitive strain is more
transmissible and can reinfect a host carrying the
resistant strain (but not vice versa), reveals the
lowest levels of coexistence over the ranges of par-
ameters sampled (approx. 10%). Figure 2d,h shows
that the sensitive strain is highly favoured, and the
probability that the resistant strain will eliminate the
sensitive strain is lower than in the other models we
consider.
For model E, which includes the possibility of
transmitting both strains simultaneously, there are
two distinct approaches to model a ﬁtness cost of
drug resistance, and these are shown in ﬁgure 3.O n e
is to model br , bs (resistance associated with lower
transmissibility) as we have done for the other
models. The other is to model rs . 1/2, which implies
that when a dually infected individual transmits a
single infection, it is more likely that the sensitive
strain will be transmitted than the resistant one.
We examine the effect of each mechanism, and also
vary the probability of single versus dual transmission
from those in the dually infectious class, choosing
rsingle ¼ 0.1, 0.5 and 0.9. Results are illustrated in
ﬁgure 3, and the numbers of simulations exhibiting
coexistence are given in table 2. We ﬁnd that two
factors increase the level of coexistence. One is to
increase the chance of simultaneous dual transmission,
which is done through lowering the value of rsingle.
The other is to implement the ﬁtness cost of resistance
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in the case that a dually infected individual transmits
a single infection (i.e. rs . 1/2). When both of
these choices are made, there is a notable coexistence-
promoting effect: almost 30 per cent of the
simulations show long-term stable coexistence
of strains (table 2).
4.2. Impact of strain-speciﬁc immunity
Classical Lotka–Volterra models indicate that when
there is more intraspeciﬁc competition (each species
inhibiting its own growth) than interspeciﬁc compe-
tition (each inhibiting the other’s growth), stable
coexistence can result (Begon et al. 1990). This suggests
that changing the ability of each strain of infection to
repress its own reproductive success, when compared
with its inhibition of the spread of the other strain,
will be a coexistence-promoting mechanism that is dis-
tinct from the mechanisms we have assessed so far. If
it is biologically plausible, one may wish to examine
this as a mechanism that promotes coexistence between
two biologically distinct strains. There are two major
ways in which a particular strain, when present,
Table 1. Parameters in the models. Where a range is given, values are uniformly distributed across that range. Where a single
value is given, the parameter was kept at that value.
parameter range description rationale
br/bs 0.75–1 ratio of transmission parameters for
resistant : sensitive strains
assumes resistant strain is never more
transmissible than the sensitive strain, but
that the minimum possible R0R for
resistant strain is 1
bs 1.33–4.33 transmission parameter for the sensitive strain R01 range from 1.33 to 4.33 and R02 range
from 1 to 3.25. Based on assuming an SIS
model and observed prevalence of carriage
in the range of 30–80% (Bogaert et al.
2004)
t1/t2 1–6 relative treatment rate in the high-treatment
environment (model C only)
assumption: estimates and 95% conﬁdence
intervals for estimates comparing infants in
day care to other infants in Scandinavia
are 2.43 (1.34–4.41) (Hedin et al. 2007)
and 2.0 (1.7–2.3) (Thrane et al. 2001). We
consider a broader range because slightly
older children may use less antibiotics
while still contributing to transmission
t1 1/12 to
1/3 per month
treatment rate in the lower treatment
compartments
Finkelstein et al. (2001), using the rates in
under-3 and under-6 children, respectively
k 1/2 to 1 1-partial immunity assumption
u 1 per month clearance rate Ekdahl et al. (1997), Hogberg et al. (2007)
c 1/2 fraction of duals returning to IS (IR) upon
reinfection with S (R)
necessary for structurally neutral model in
simple model when strains are
indistinguishable (Lipsitch et al. 2009)
q 1/2 relative infectiousness with each strain for
dually infecteds (ISR); enforces that dually
infecteds as infectious as singly infecteds
necessary for structurally neutral model in
simple model when strains are
indistinguishable (Lipsitch et al. 2009)
z2/z1 1–5 relative contact rate in the high-contact
environment (model C only)
assumption
z1 1 base contact factor in the day care/school/
work model (model C)
null value
h 0.05–0.5 portion of population in the high-contact
compartment (model C)
widest reasonable range
g 0–1 type of mixing in model C. 0 is random
mixing, 1 is assortative mixing
full range
w 3–8 per month rate of treatment waning in treated class
model (model B)
length of treatment: approximately 4–10
days
rsingle 0.1, 0.5, 0.9 probability that a single (rather than dual)
infection is transmitted (model E)
symmetric value 0.5. Explored 0.1 and 0.9
effect on coexistence
rs 0.5–1 probability that S is transmitted when a
dually infected individual transmits single
infection (model E)
symmetric value 0.5. Larger values model a
ﬁtness cost of resistance through giving an
advantage to strain S
j 1/10 to 10 per
month
within-host takeover rate at which IRS ! ISR
(model E)
range of two orders of magnitude with
concentration at low takeover rate (this
parameter is sampled uniformly on log
scale)
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strain than with other strains. The ﬁrst is specialization
of strains, for example, if each strain had an afﬁnity for
a different host receptor or anatomic site; in this case,
colonization of an already-colonized host by a different
strain would tend to be easier than colonization by
another population of the same strain that is already
present. Second, if each strain elicits—while present
in the nasopharynx—an immune response that tends
to inhibit itself more than the other strain, then
once more a host would be more open to acquisition
of a strain that is not present than to recolonization
by another copy of a strain that is already present.
Both of these mechanisms are in effect forms of
within-host, strain-speciﬁc niche differentiation, and
we will use the shorter term ‘niche differentiation’ to
describe such mechanisms in general. In this section,
we consider the effects of niche differentiation on
coexistence.
In our simple model, an individual infected with
strain S can be reinfected with strain R, leading to
dual colonization; the presence of a strain already
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Figure 2. Scatter plots of the simulations in the (a) simple (model A), (b) treated (model B), (c) day care/school/work (model C)
and (d) within-host strain takeover models (model D) showing their outcomes at equilibrium and (e–h) histograms of the fraction
of infection that is resistant at equilibrium. Green, coexistence; blue, all disease is strain S; red, all disease is strain R.
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by a proportion (1 2 k), relative to the rate of primary
infections in non-colonized persons. Thus, the tran-
sition term from IS to IR is kbr(IR þ qISR)IS. In that
model, we also assume that a host colonized with
both strains may be colonized again by one of the
strains, ‘knocking out’ the other and sending the host
back into the singly colonized. It is assumed there
that such knocking-out occurs at the same rate as sec-
ondary infection, with half of these events being
‘invisible’ because the incoming and outgoing strains
are the same (c ¼ 1/2). Thus, the transition term
from ISR to IS, for example, is ckbs(IS þ qISR)ISR.
However, if it were the case that individuals already
colonized with, for example, strain S are less likely to
acquire another strain S than to acquire strain R, and
vice versa (owing to niche differentiation), then these
terms for knocking-out in hosts colonized with both
S and R would be reduced, e.g. ckobs(ISþqISR)ISR,
with ko , k.
We repeat the simulations presented above, but with
ko ¼ fk, for f ¼(1/2, 5/8, 3/4, 7/8); to facilitate
comparison between probabilities of coexistence over
the four new values of f, we used parameter sets that
were identical (for all parameters common to the
models) with the exception of this single variable.
Table 3 summarizes the results, including those for
f ¼ 1. We do not consider model D here because a dis-
tinctive feature of model D is that it does not permit
a strain to reinfect a host already carrying that strain,
so self-immunity is not an issue.
Increasing strain-speciﬁc immunity is associated with
a marked increase in the possibility of stable coexistence
in all the models.
While the day-care model and the dual transmission
model reach similar, and high, levels of coexistence
when ko ¼ k/2, the dual transmission model does so
while remaining relatively neutral in terms of how
much resistance there is overall in the simulations,
while the day-care model substantially promotes resist-
ance in this case. Figure 5 in appendix A presents this
difference visually through histograms of the fraction
of infection that is resistant in the simulations,
analogous to those presented in ﬁgure 3.
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The mechanisms that maintain intermediate levels of
drug resistance among pneumococcal isolates in diverse
geographical areas—which differ substantially in both
the prevalence of infection and the usage of anti-
biotics—are not well understood. The simplest
dynamic models that consider strict competition
between strain types (in the absence of acquired or
imported resistance) predict either the complete take-
over or the disappearance of resistance; the strain that
eventually dominates is determined by the balance of
ﬁtness costs imposed by resistance and the selective
pressure of antibiotics. The failure of these simple
models to account for the long-term coexistence of drug-
resistant and drug-sensitive isolates of S. pneumoniae
indicates that more realistic models are necessary to
explain how phenotypic variants are maintained within
a single population of hosts.
One such model explicitly includes a class of individ-
uals on antibiotic therapy; hence there was a protected
niche in which drug-resistant strains could ﬂourish even
if they were outcompeted among the larger population
of hosts who were not currently on treatment
(Austin & Anderson 1999). On the ecological principle
that habitat heterogeneity leads to coexistence of
competitors via specialization (Tilman 1982), we
hypothesized that insular subpopulations of individuals,
such as children in day care who are in close contact and
also highly exposed to commonly used antibiotics, offer a
refuge for relatively ‘unﬁt’ resistant strains that would be
outcompeted if mixing between all individuals was
random and antibiotic pressure was equally applied.
Finally, we suspected that if there were two levels of com-
petition, within a host and in the transmitting host
population, specialization might occur and permit coex-
istence, as has been seen in infectious disease models in
other contexts (Levin & Pimentel 1981).
In previous work (Lipsitch et al. 2009), we argue that
models for exploring mechanisms of coexistence should
not artiﬁcially facilitate strain coexistence by incorporat-
ing implicit mechanisms that protect strains from
elimination. Instead, we advocate the use of structurally
neutral models, which do not permit asymptotically
stable coexistence of indistinguishable strains, as a basis
on which mechanisms that may promote coexistence
(such as host population heterogeneity or within- versus
between-host tradeoffs) can be layered. Here, we follow
this advice, starting from models that are neutral when
applied to indistinguishable strains and then asking
whether they typically permit stable coexistence of
sensitive and resistant strains.
We have used the portion of simulations exhibiting
long-term coexistence as a metric for how robust coex-
istence is in a given model structure. Of course, this
portion will depend on the distribution from which
parameter values are drawn. We have modelled par-
ameters being independent and uniformly distributed
over ranges informed where possible by empirical
observations; the parameters were taken from the
same ranges in each model and models were con-
structed as much as possible so that a parameter
has the same meaning in each model. Thus, we
would argue that the comparative conclusions of our
work regarding which model structures have the
most robust coexistence are to some extent indepen-
dent of the parameter distributions so long as these
are held ﬁxed.
One could take an alternative approach; for example,
consider model A and ﬁgure 4 in appendix A. Here,
coexistence would only be a generic outcome if par-
ameters were taken from a distribution supported
primarily on the thin band in parameter space where
there is stable coexistence. However, in light of factors
such as variation in treatment programmes and anti-
biotic usage in different settings, contact and host
heterogeneity and other factors, it seems less likely
that parameter values would be so tightly constrained
and interdependent than that there is a model structure
for which coexistence is a more robust outcome. It is
this comparison between model structures that we
hope to elucidate with our approach.
We ﬁnd, ﬁrst, that stable coexistence is possible in a
simple model of single and dual colonization (model
A), even when it is designed to meet the criteria for
a structurally neutral model. However, the proportion
of parameter sets for which stable coexistence is found
is only 16 per cent, which suggests that coexistence is
not a typical outcome for such a model. In the treated
class model (model B), we had hypothesized that a
treated class would provide a reservoir of susceptible
individuals accessible only to the resistant strain,
thus preventing competitive exclusion of this less ﬁt
strain and increasing the possibility of coexistence.
While the proportion of parameter sets permitting
coexistence was slightly higher (19%), the major
effect of including a treated class was to promote
resistance, by moving susceptible individuals to
states where they are only available to the resistant
strain, thus affecting the competition for hosts
between the two strains. This effect is clearly visible
from a comparison of the histograms in ﬁgure 2e,f,
which shows many more parameter sets generating a
‘resistant-only’ outcome in model B.
Table 3. Per cent of simulations coexisting in the models
when self-protection is greater than cross-protection.
f 1/25 /83 /47 /81
model A: simple 69 59 47 32 16
model B: treated class 62 53 42 31 19
model C: day care 80 73 62 43 20
model E: dual transmission 79 71 61 47 29
Table 2. Probability of long-term coexistence in the
simultaneous dual transmission model.
ﬁtness through
br , bs (%)
ﬁtness through
rs .1/2 (%)
rsingle ¼ 0.1 21 29
rsingle ¼ 0.5 20 21
rsingle ¼ 0.9 17 16
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lations that differ in two ways—in their rates of contact
and in their rates of treatment. We hypothesized that
such heterogeneity would lead to a greater likelihood of
coexistence, with resistant and sensitive strains specializ-
ing in the high- and low-treatment populations,
respectively. As an extreme case, one can imagine that
the population is split into two groups: one in which
one strain takes over and a second in which the other
strain takes over. This could occur, for example, if the
basic reproductive number of the sensitive strain is
larger than that of the resistant strain in the general
population, but in the day-care population, owing to
treatment, the basic reproductive number of the resistant
strain is higher. If there were no mixing between groups,
this situation would result in coexistence of strain types if
each strain can exclude the other in only one of the two
non-intermixing subpopulations. Indeed, in model C,
coexistence is promoted to some degree when mixing is
strongly assortative, but even a small amount of
mixing between the groups tends to counteract the
effects of host heterogeneity. In summary, model C
slightly promotes coexistence, but only when mixing
between groups is very low. Compared with model A,
model C predicts more success for the resistant strain
(ﬁgure 2c,g), just as with model B. In contrast, model
D, which allows superinfection and subsequent within-
host takeover only by the more ﬁt drug-sensitive strain,
has little coexistence-promoting effect, but does favour
the sensitive strain relative to model A (ﬁgure 2d,h).
The most robust coexistence among our initial models
is found in model E, which allows for simultaneous dual
transmission of infections, so that a susceptible
individual may obtain both an S and an R infection
directly upon contacting a dually infected individual.
In this model, it is possible to obtain comparatively
high frequencies of stable coexistence. While this depends
on how the ﬁtness costs associated with resistant
phenotypes are modelled, and also relies on a reasonably
high likelihood of simultaneous dual transmission, it
occurs naturally in a model that meets the criteria for
biologically identical strains without introducing
coexistence of indistinguishable strains for free.
Most favourable to stable coexistence is the assump-
tion that drug-sensitive and drug-resistant strains
compete more strongly with themselves than with one
another. The choice to have self- and cross-immunity
differ depends on the two strains being substantially
different in their immunogenic properties, and hence
does not ﬁt the framework of structurally neutral
models, despite the fact that it can be applied sym-
metrically to the strains. The question, then, is whether
such a mechanism is biologically plausible. We are aware
of no evidence that drug-resistance determinants them-
selves provide protective immunity to pneumococcal
colonization or otherwise deﬁne niche differentiation.
However, drug resistance does tend to be associated with
particular serotypes of S. pneumoniae (McGee et al.
2001; McCormick et al. 2003). Serotype-speciﬁc immunity
to pneumococcal carriage has been documented for some
serotypes (Goldblatt et al. 2005; Hill et al. 2008;
Weinberger et al. 2008), and there is considerable evidence
for the biological and epidemiological heterogeneity of
serotypes (Hausdorff et al. 2005), which may in part lead
t o( o rr e ﬂ e c t )n i c h ed i f f e r e n t i a t i o n .T h u s ,i ti sb i o l o g i c a l l y
possible that resistant strains and sensitive strains will,
on average, compete more strongly with themselves than
with one another.
In this study, we have considered and rejected several
mathematical models solely based on the qualitative
criterion of coexistence between sensitive and resistant
strains of bacteria. Only two of the models considered
showed coexistence in at least 20 per cent of sampled
parameters, a rather generous criterion for calling
coexistence a ‘typical’ outcome; this fraction was much
higher if strain-speciﬁc immunity was considered.
Further work should allow us to further constrain the
range of plausible models—thereby improving our bio-
logical understanding—by considering additional
quantitative aspects of pneumococcal surveillance data.
Overall resistance levels correlate well with country-
wide antibiotic usage statistics (Goossens et al.2 0 0 5 ),
and vary seasonally in phase with antibiotic usage,
which peaks in winter months (Dagan et al.2 0 0 8 ).
Future work should aim to replicate quantitatively this
high degree of spatial and temporal correlation between
antibiotic consumption and the frequency of resistance.
Other factors, including spatial heterogeneity, trade-
offs in transmissibility and virulence, contact structure,
heterogeneoushostsusceptibilityandmechanismsforsus-
tained non-equilibrium coexistence, are all likely to play a
role in maintaining strain diversity. Furthermore, differ-
ent pathogens will probably be differently affected by
such mechanisms; there is no unique mechanism for the
promotion of coexistence. However, the results presented
here indicate that the within-host interactions between
thestrains,inparticularthedynamicsofcoinfection,mul-
tiple infections and strain replacement, have a marked
effect on the population-level strain composition and the
possibility of long-term coexistence.
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Figure 4. Bifurcation diagram for the simple model, showing
the regions of stability of the four equilibria: no disease,
strain S or R takeover and stable coexistence.
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Bifurcation diagram for the simple model and histograms
of the per cent of simulation with coexistence at
equilibrium in each model are shown in ﬁgures 4 and 5.
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